Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SOMA COMPOUND W/ CODEINE

ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE

Standard Dose
325MG;200MG;16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SOMA COMPOUND W/ CODEINE is listed in Drugs@FDA under application 012366 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE Form and strength TABLET;ORAL - 325MG;200MG;16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MEDA PHARMS Submission history Latest submission status date: 2013-05-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview SOMA COMPOUND W/ CODEINE is listed in Drugs@FDA under application 012366 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE Form and strength TABLET;ORAL - 325MG;200MG;16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MEDA PHARMS Submission history Latest submission status date: 2013-05-09 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
SOMA COMPOUND W/ CODEINE (ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE) | Drug Monograph | MedicHelpline